Insider holders · CIK 0002088082
Electra Therapeutics, Inc. · ETRA
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Westlake BioPartners GP I, LLC10% Owner | — | 2,820,403 | 2,820,403 | Sep 21, 2026 · 9:01 pm EDT | Form 3 |
| Westlake BioPartners GP II, LLC10% Owner | — | 2,820,403 | 2,820,403 | Sep 21, 2026 · 9:01 pm EDT | Form 3 |
| Westlake BioPartners Fund II, L.P.10% Owner | — | 2,820,403 | 2,820,403 | Sep 21, 2026 · 9:01 pm EDT | Form 3 |
| Westlake BioPartners Fund I, L.P.10% Owner | — | 2,820,403 | 2,820,403 | Sep 21, 2026 · 9:01 pm EDT | Form 3 |
| OrbiMed Genesis GP LLCDirector | — | 1,758,279 | 1,758,279 | Sep 23, 2026 · 5:29 pm EDT | Form 4 |
| OrbiMed Capital GP VII LLCDirector | — | 1,758,279 | 1,758,279 | Sep 23, 2026 · 5:29 pm EDT | Form 4 |
| Carl L GordonDirector | — | 1,758,279 | 1,758,279 | Sep 23, 2026 · 5:35 pm EDT | Form 4 |
| ORBIMED ADVISORS LLCDirector | — | 1,758,279 | 1,758,279 | Sep 23, 2026 · 5:29 pm EDT | Form 4 |
| Quehuong (Kathy) DongPresident & CEO | 455,484 | — | 455,484 | Sep 21, 2026 · 6:14 pm EDT | Form 4 |
| Nancy StaglianoDirector | 255,635 | — | 255,635 | Sep 21, 2026 · 6:19 pm EDT | Form 4 |
| Graham ParryChief Scientific Officer | 85,504 | — | 85,504 | Sep 21, 2026 · 6:17 pm EDT | Form 4 |
| Gary S. KoeChief Technical Officer | 63,656 | — | 63,656 | Sep 21, 2026 · 6:20 pm EDT | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.